Cancer Genetics IncMost Recent.Company & Industry OverviewsTMO’s Oncomine Dx Target Test Gets CMS CoverageOn December 7, 2017, Thermo Fisher Scientific (TMO) announced that its Oncomine Dx Target Test had been proposed for coverage by the CMS (Centers for Medicare & Medicaid Services). .Company & Industry OverviewsTMO’s Oncomine Target Test Launch Will Boost This BusinessOn June 27, 2017, Thermo Fisher Scientific announced the launch of its Oncomine Dx Target Test.
.Company & Industry OverviewsTMO’s Oncomine Dx Target Test Gets CMS CoverageOn December 7, 2017, Thermo Fisher Scientific (TMO) announced that its Oncomine Dx Target Test had been proposed for coverage by the CMS (Centers for Medicare & Medicaid Services).
.Company & Industry OverviewsTMO’s Oncomine Target Test Launch Will Boost This BusinessOn June 27, 2017, Thermo Fisher Scientific announced the launch of its Oncomine Dx Target Test.
